Related Experiment Videos
Antidepressants do not increase the lethality of ketamine in mice
Abstract:
Swiss-Webster mice were allocated to 35 groups of 20 each, including controls, to evaluate the effect of pretreatment with antidepressant drugs on the LD50 of ketamine i.p. Deaths occurred only in groups given ketamine 400 or 600 mg kg-1. Within these groups, there were no consistent differences among untreated mice and those given one of three daily doses of either a tricyclic (amitriptyline) or monoamine oxidase inhibitor (tranylcypromine) antidepressant in their drinking water for 19 days before the ketamine injections. The ketamine LD50 values for the three major pretreatment groups were: controls 400 mg kg-1; amitriptyline 478 mg kg-1; tranylcypromine 483 mg kg-1. Although non-fatal additive toxicity is not ruled out by these findings, mortality from ketamine was not increased by pretreatment with either type of antidepressant.
Insights
Pretreatment with antidepressant drugs did not increase mortality from ketamine in mice. This study evaluated the effects of tricyclic and monoamine oxidase inhibitor antidepressants on ketamine
Area of Science:
- Pharmacology
- Toxicology
- Neuroscience
Background:
- Ketamine is an anesthetic with potential for toxicity.
- Antidepressant drugs are widely used and may interact with other medications.
- Understanding drug interactions is crucial for patient safety.
Purpose of the Study:
- To investigate the impact of chronic antidepressant pretreatment on ketamine's median lethal dose (LD50).
- To assess potential synergistic or antagonistic effects between common antidepressants and ketamine on mortality.
Main Methods:
- Swiss-Webster mice were divided into 35 groups (20 mice per group).
- Mice received daily doses of amitriptyline or tranylcypromine for 19 days prior to intraperitoneal ketamine administration.
- Ketamine LD50 was determined for control and pretreated groups.
Main Results:
- Deaths only occurred at high ketamine doses (400 and 600 mg/kg).
- No significant differences in mortality were observed between control mice and those pretreated with amitriptyline or tranylcypromine.
- Calculated ketamine LD50 values were 400 mg/kg for controls, 478 mg/kg for amitriptyline, and 483 mg/kg for tranylcypromine.
Conclusions:
- Pretreatment with tricyclic or monoamine oxidase inhibitor antidepressants does not increase acute mortality from ketamine in mice.
- While non-fatal additive toxicity cannot be excluded, these findings suggest no significant interaction on ketamine lethality.
- Further research may explore sub-lethal effects or different drug combinations.